These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19838939)

  • 21. γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer.
    Campbell SE; Rudder B; Phillips RB; Whaley SG; Stimmel JB; Leesnitzer LM; Lightner J; Dessus-Babus S; Duffourc M; Stone WL; Menter DG; Newman RA; Yang P; Aggarwal BB; Krishnan K
    Free Radic Biol Med; 2011 May; 50(10):1344-54. PubMed ID: 21335085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
    Chintharlapalli S; Papineni S; Safe S
    Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme association with PPARgamma: evidence of a new role for 15-lipoxygenase type 2.
    Flores AM; Li L; McHugh NG; Aneskievich BJ
    Chem Biol Interact; 2005 Jan; 151(2):121-32. PubMed ID: 15698583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R; Mitchell SH; Tindall DJ; Young CY
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
    Galli F; Stabile AM; Betti M; Conte C; Pistilli A; Rende M; Floridi A; Azzi A
    Arch Biochem Biophys; 2004 Mar; 423(1):97-102. PubMed ID: 14871472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.
    Lea MA; Sura M; Desbordes C
    Anticancer Res; 2004; 24(5A):2765-71. PubMed ID: 15517883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
    Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.
    Liu DC; Zang CB; Liu HY; Possinger K; Fan SG; Elstner E
    Acta Pharmacol Sin; 2004 Oct; 25(10):1312-9. PubMed ID: 15456533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between peroxisome proliferator activator-receptor (PPAR) and urological cancer].
    Yoshimura R; Nakatani T
    Nihon Rinsho; 2005 Apr; 63(4):672-8. PubMed ID: 15828236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
    Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
    Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.